President Trump’s nominee to lead the Food and Drug Administration, Stephen M. Hahn, will face questions this morning on many of the pressing health topics facing the nation when he appears tomorrow before the Senate Health, Education, Labor, and Pensions (HELP) Committee. Members of the committee will likely ask about hot topics like vaping among youth, the opioid crisis, and persistent delays in approvals for drugs and medical devices.
No less crucial is the impact that proliferating misleading labels on food products is having on the American public and future of innovation. It may not drive scary headlines but it affects every person who shops at a grocery store and must be raised with Hahn.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.